1. Vertex Pharmaceuticals, Inc.
  2. Vertex Pharmaceuticals, Inc. Ownership

Historical shareholding details of Nuveen Asset Management, LLC holdings in Vertex Pharmaceuticals, Inc. (VRTX)

Monthly changes of Nuveen Asset Management, LLC shareholding in Vertex Pharmaceuticals, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Nuveen Asset Management, Llc 0 0.00%
Feb 28, 2025 Nuveen Asset Management, Llc 0 0.00%
Jan 31, 2025 Nuveen Asset Management, Llc 0 0.00%
Dec 31, 2024 Nuveen Asset Management, Llc 1,051,111 0.41%
Dec 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Nov 30, 2024 Nuveen Asset Management, Llc 0 0.00%
Oct 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Sep 30, 2024 Nuveen Asset Management, Llc 789,220 0.31%
Sep 30, 2024 Nuveen Asset Management, Llc 0 0.00%
Aug 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Jul 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Jun 30, 2024 Nuveen Asset Management, Llc 804,350 0.31%
Jun 30, 2024 Nuveen Asset Management, Llc 0 0.00%
May 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Apr 30, 2024 Nuveen Asset Management, Llc 0 0.00%
Mar 31, 2024 Nuveen Asset Management, Llc 835,717 0.32%
Mar 31, 2024 Nuveen Asset Management, Llc 0 0.00%
Feb 29, 2024 Nuveen Asset Management, Llc 62 0.00%
Jan 31, 2024 Nuveen Asset Management, Llc 62 0.00%
Dec 31, 2023 Nuveen Asset Management, Llc 841,123 0.33%
Dec 31, 2023 Nuveen Asset Management, Llc 91 0.00%
Nov 30, 2023 Nuveen Asset Management, Llc 91 0.00%
Oct 31, 2023 Nuveen Asset Management, Llc 91 0.00%
Sep 30, 2023 Nuveen Asset Management, Llc 812,587 0.31%
Sep 30, 2023 Nuveen Asset Management, Llc 91 0.00%
Aug 31, 2023 Nuveen Asset Management, Llc 91 0.00%
Jul 31, 2023 Nuveen Asset Management, Llc 91 0.00%
Jun 30, 2023 Nuveen Asset Management, Llc 851,992 0.33%
Jun 30, 2023 Nuveen Asset Management, Llc 157 0.00%
May 31, 2023 Nuveen Asset Management, Llc 157 0.00%
Mar 31, 2023 Nuveen Asset Management, Llc 908,328 0.35%
Dec 31, 2022 Nuveen Asset Management, Llc 910,031 0.35%

View all ownership details of Vertex Pharmaceuticals, Inc.